Haakon Eduard Meyer

Haakon Eduard Meyer

Auto-generated profile, based on publicly available information

Haakon Eduard Meyer

Department of Physical Health and Ageing, Norwegian Institute of Public Health, Oslo, Norway

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2006 in Journal of Cell Biology
Verified
Journal Article
Open access
AFAnn Frazier
Ann Frazier
RTRebecca D. Taylor
Rebecca D. Taylor
DMDavid U. Mick
David U. Mick
BWBettina Warscheid
Bettina Warscheid
NSNadine Stoepel
Nadine Stoepel
PRPeter Rehling
Peter Rehling
Saccharomyces cerevisiae Mdm38 and Ylh47 are homologues of human Letm1, a protein implicated in Wolf-Hirschhorn syndrome. We analyzed the function of Mdm38 and Ylh47 in yeast mitochondria to gain insight into the role of Letm1. We find that mdm38Δ mitochondria have reduced amounts of certain mitochondrially encoded proteins and low levels of complex III and IV and accumulate unassembled Atp6 of complex V of the respiratory chain. Mdm38 is especially required for efficient transport of Atp6 and cytochrome b across the inner membrane, whereas Ylh47 plays a minor role in this process. Both Mdm38 and Ylh47 form stable complexes with mitochondrial ribosomes, similar to what has been reported for Oxa1, a central component of the mitochondrial export machinery. Our results indicate that Mdm38 functions as a component of an Oxa1-independent insertion machinery in the inner membrane and that Mdm38 plays a critical role in the biogenesis of the respiratory chain by coupling ribosome function to protein transport across the inner membrane.

7 September 2022 in BMJ
Verified
Journal Article
Open access
PDF file
SBSonja H Brunvoll
Sonja H Brunvoll
ANAnders B Nygaard
Anders B Nygaard
MEMerete Ellingjord-Dale
Merete Ellingjord-Dale
PHPetter Holland
Petter Holland
MIMette Stausland Istre
Mette Stausland Istre
ASArne Søraas
Arne Søraas
Objective To determine if daily supplementation with cod liver oil, a low dose vitamin D supplement, in winter, prevents SARS-CoV-2 infection, serious covid-19, or other acute respiratory infections in adults in Norway. Design Quadruple blinded, randomised placebo controlled trial. Setting Norway, 10 November 2020 to 2 June 2021. Participants 34 601 adults (aged 18-75 years), not taking daily vitamin D supplements. Intervention 5 mL/day of cod liver oil (10 µg of vitamin D, n=17 278) or placebo (n=17 323) for up to six months. Main outcome measures Four co-primary endpoints were predefined: the first was a positive SARS-CoV-2 test result determined by reverse transcriptase-quantitative polymerase chain reaction and the second was serious covid-19, defined as self-reported dyspnoea, admission to hospital, or death. Other acute respiratory infections were indicated by the third and fourth co-primary endpoints: a negative SARS-CoV-2 test result and self-reported symptoms. Side effects related to the supplementation were self-reported. The fallback method was used to handle multiple comparisons. Results Supplementation with cod liver oil was not associated with a reduced risk of any of the co-primary endpoints. Participants took the supplement (cod liver oil or placebo) for a median of 164 days, and 227 (1.31%) participants in the cod liver oil group and 228 (1.32%) participants in the placebo group had a positive SARS-CoV-2 test result (relative risk 1.00, multiple comparison adjusted confidence interval 0.82 to 1.22). Serious covid-19 was identified in 121 (0.70%) participants in the cod liver oil group and in 101 (0.58%) participants in the placebo group (1.20, 0.87 to 1.65). 8546 (49.46%) and 8565 (49.44%) participants in the cod liver oil and placebo groups, respectively, had ≥1 negative SARS-CoV-2 test results (1.00, 0.97 to 1.04). 3964 (22.94%) and 3834 (22.13%) participants in the cod liver oil and placebo groups, respectively, reported ≥1 acute respiratory infections (1.04, 0.97 to 1.11). Only low grade side effects were reported in the cod liver oil and placebo groups. Conclusion Supplementation with cod liver oil in the winter did not reduce the incidence of SARS-CoV-2 infection, serious covid-19, or other acute respiratory infections compared with placebo. Trial registration ClinicalTrials.gov NCT04609423.

13 July 2006 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
FTF. Tribl
F. Tribl
Katrin MarcusKatrin Marcus
Katrin Marcus
GBGerhard Bringmann
Gerhard Bringmann
HMH. E. Meyer
H. E. Meyer
MGM. Gerlach
M. Gerlach
PRPeter Riederer
Peter Riederer

3 March 1990 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
HMHelmut E. Meyer
Helmut E. Meyer
GMGerhard F. Meyer
Gerhard F. Meyer
HDHerbert Dirks
Herbert Dirks
LHLudwig M. G. Heilmeyer
Ludwig M. G. Heilmeyer
The α subunit of skeletal muscle phosphorylase kinase, as isolated, carries phosphate at the serine residues 1018, 1020 and 1023. Employing the S‐ethyl‐cysteine method, these residues are found to be phosphorylated partially, i.e. differently phosphorylated species exist in muscle. Serine 1018 is a site which can be phosphorylated by the cyclic‐AMP‐dependent protein kinase. The serine residues 972, 985 and 1007 are phosphorylated by phosphorylase kinase itself when its activity is stimulated by micromolar concentrations of Ca2+. These phosphorylation sites are not identical to those found to be phosphorylated already in the enzyme as prepared from freshly excised muscle. A ‘multiphosphorylation loop’ uniquely present in this but not in the homologous β subunit contains all the phosphoserine residues so far identified in the α subunit.

13 November 2023 in Food & Nutrition Research
Verified
Journal Article
Open access
PDF file
MBMagritt Brustad
Magritt Brustad
HMHaakon E. Meyer
Haakon E. Meyer
Vitamin D is an essential nutrient. Its role in calcium and phosphorous metabolism, and in the development and maintenance of a healthy skeleton is well documented. In addition, there is some evidence for vitamin D decreasing total mortality and cancer mortality modestly, but not cancer incidence. Vitamin D is unique, as both diet and sun induced production in skin are sources to this vitamin. Individual vitamin D status is thus a sum of both sun exposure and dietary intakes. The discovery of vitamin D receptors and the activation of biological active vitamin D in numerous tissues and organs in the body has given support to hypothesis on vitamin D having extra-skeletal functions. The scientific literature on vitamin D and several health outcomes is high in numbers and has been increasing exponentially the last two decades. However, despite this large body of scientific publications and improvement in study quality, vitamin D supplementation has not shown to give additional health benefits when status is in sufficient range (i.e. circulating 25 hydroxyvitamin D >50 nmol/L). Well-designed studies on insufficient or deficient individuals are lacking. The totality of evidence does not support that increased intake of vitamin D beyond current recommendation will have additional beneficial health effects.

18 November 2019 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
MHM. Hoff
M. Hoff
ESEva Skovlund
Eva Skovlund
SSS. Skurtveit
S. Skurtveit
HMH.E. Meyer
H.E. Meyer
ALA. Langhammer
A. Langhammer
BSB. Schei
B. Schei